Valeo Pharma Inc. (VPHIF)

Market Cap	99.00 -100.0%
Revenue (ttm)	38.64M -0.2%
Net Income	-23.25M
EPS	-0.26
Shares Out	98.68M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500
Open	0.000001
Previous Close	0.000001
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0003
Beta	0.80
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Valeo Pharma

Valeo Pharma Inc. operates as a pharmaceutical company focused on licensing, acquiring, and commercializing drugs. The company provides commercialized pharmaceutical products in Canada, with a focus on respiratory/allergy, ophthalmology, and specialty therapeutic areas. It licenses and acquires Canadian rights to commercial-stage and proprietary drugs, managing registration and commercialization through all stages. The company offers access to product specialists and medical information for healthcare professionals and patients. Valeo Pharma se...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 70
• Stock Exchange: OTCMKTS
• Ticker Symbol: VPHIF

Financial Performance

In fiscal year 2023, Valeo Pharma's revenue was 53.91 million, an increase of 94.31% compared to the previous year's 27.75 million. Losses were -27.81 million, 8.01% more than in 2022.

Financial numbers in CAD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 26, 2026

Data Sources Report a data error